Advertisement

Complete Hydatidiform Mole

Chapter
  • 899 Downloads
Part of the Current Clinical Pathology book series (CCPATH)

Abstract

Complete mole, also known as “classic” hydatidiform mole, is the prototype of molar gestation bearing the traditional description of “hydatid,” for example, grape-like structures at the time of evacuation, a term that was used throughout the last century. The historical tale of “365 babies” of the Dutch’s Countess Margaret of Henneberg (Chap. 1) clearly documented a case of a well-developed complete mole some 700 years ago. It is important to note that essentially all meaningful epidemiology data of hydatidiform mole in the literature have been based on studies of complete mole rather than partial moles. Epidemiological data on partial hydatidiform mole have been at best unreliable, largely because of significant diagnostic inaccuracy in practice, even at present time (see Chap. 1).

Keywords

Complete mole Early complete mole Diagnostic features 

References

  1. 1.
    Benirschke K, Kaufmann P, Baergen RN. Pathology of the human placenta. 5th ed. New York: Springer; 2006.Google Scholar
  2. 2.
    Bebyser IWJ, Soma H, Zwart P. Partial hydatidiform mole in a pregnant chimpanzee (Pan troglodytes). Zoo Biol. 1993;12:6.Google Scholar
  3. 3.
    Gopal T, Leipold HW, Dennis SM. Hydatidiform moles in Holstein cattle. Vet Rec. 1980;107(17):395–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Lage JM, Weinberg DS, Yavner DL, Bieber FR. The biology of tetraploid hydatidiform moles: histopathology, cytogenetics, and flow cytometry. Hum Pathol. 1989;20(5):419–25.PubMedCrossRefGoogle Scholar
  5. 5.
    Vejerslev LO, Dissing J, Hansen HE, Poulsen H. Hydatidiform mole: genetic origin in polyploid conceptuses. Hum Genet. 1987;76(1):11–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Baasanjav B, Usui H, Kihara M, Kaku H, Nakada E, Tate S, et al. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles. Hum Reprod. 2010;25(5):1183–91.PubMedCrossRefGoogle Scholar
  7. 7.
    Fisher RA, Hodges MD, Newlands ES. Familial recurrent hydatidiform mole: a review. J Reprod Med. 2004;49(8):595–601.PubMedGoogle Scholar
  8. 8.
    Williams D, Hodgetts V, Gupta J. Recurrent hydatidiform moles. Eur J Obstet Gynecol Reprod Biol. 2010;150(1):3–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Fisher RA, Hodges MD, Rees HC, Sebire NJ, Seckl MJ, Newlands ES, et al. The maternally transcribed gene p57(KIP2) (CDNK1C) is abnormally expressed in both androgenetic and biparental complete hydatidiform moles. Hum Mol Genet. 2002;11(26):3267–72.PubMedCrossRefGoogle Scholar
  10. 10.
    Panichkul PC, Al-Hussaini TK, Sierra R, Kashork CD, Popek EJ, Stockton DW, et al. Recurrent biparental hydatidiform mole: additional evidence for a ­1.1-Mb locus in 19q13.4 and candidate gene analysis. J Soc Gynecol Investig. 2005;12(5):376–83.PubMedCrossRefGoogle Scholar
  11. 11.
    Murdoch S, Djuric U, Mazhar B, Seoud M, Khan R, Kuick R, et al. Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet. 2006;38(3):300–2.PubMedCrossRefGoogle Scholar
  12. 12.
    Moglabey YB, Kircheisen R, Seoud M, El Mogharbel N, Van den Veyver I, Slim R. Genetic mapping of a maternal locus responsible for familial hydatidiform moles. Hum Mol Genet. 1999;8(4):667–71.PubMedCrossRefGoogle Scholar
  13. 13.
    Hodges MD, Rees HC, Seckl MJ, Newlands ES, Fisher RA. Genetic refinement and physical mapping of a biparental complete hydatidiform mole locus on chromosome 19q13.4. J Med Genet. 2003;40(8):e95.PubMedCrossRefGoogle Scholar
  14. 14.
    Hayward BE, De Vos M, Talati N, Abdollahi MR, Taylor GR, Meyer E, et al. Genetic and epigenetic analysis of recurrent hydatidiform mole. Hum Mutat. 2009;30(5):E629–39.PubMedCrossRefGoogle Scholar
  15. 15.
    Slim R, Mehio A. The genetics of hydatidiform moles: new lights on an ancient disease. Clin Genet. 2007;71(1):25–34.PubMedCrossRefGoogle Scholar
  16. 16.
    Berkowitz RS, Goldstein DP. Chorionic tumors. N Engl J Med. 1996;335(23):1740–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Goldstein DP, Berkowitz RS. Current management of complete and partial molar pregnancy. J Reprod Med. 1994;39(3):139–46.PubMedGoogle Scholar
  18. 18.
    Berkowitz RS, Goldstein DP. Clinical practice. Molar pregnancy. N Engl J Med. 2009;360(16):1639–45.PubMedCrossRefGoogle Scholar
  19. 19.
    Berkowitz R, Ozturk M, Goldstein D, Bernstein M, Hill L, Wands JR. Human chorionic gonadotropin and free subunits’ serum levels in patients with partial and complete hydatidiform moles. Obstet Gynecol. 1989;74(2):212–6.PubMedGoogle Scholar
  20. 20.
    Szulman AE, Surti U. The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations. Am J Obstet Gynecol. 1978;131(6):665–71.PubMedGoogle Scholar
  21. 21.
    Szulman AE. Syndromes of hydatidiform moles. Partial vs. complete. J Reprod Med. 1984;29(11):788–91.PubMedGoogle Scholar
  22. 22.
    Soto-Wright V, Bernstein M, Goldstein DP, Berkowitz RS. The changing clinical presentation of complete molar pregnancy. Obstet Gynecol. 1995;86(5):775–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Felemban AA, Bakri YN, Alkharif HA, Altuwaijri SM, Shalhoub J, Berkowitz RS. Complete molar pregnancy. Clinical trends at King Fahad Hospital, Riyadh, Kingdom of Saudi Arabia. J Reprod Med. 1998;43(1):11–3.PubMedGoogle Scholar
  24. 24.
    Keep D, Zaragoza MV, Hassold T, Redline RW. Very early complete hydatidiform mole. Hum Pathol. 1996;27(7):708–13.PubMedCrossRefGoogle Scholar
  25. 25.
    Sebire NJ, Rees H, Paradinas F, Seckl M, Newlands E. The diagnostic implications of routine ultrasound examination in histologically confirmed early molar pregnancies. Ultrasound Obstet Gynecol. 2001;18(6):662–5.PubMedCrossRefGoogle Scholar
  26. 26.
    Mosher R, Goldstein DP, Berkowitz R, Bernstein M, Genest DR. Complete hydatidiform mole. Comparison of clinicopathologic features, current and past. J Reprod Med. 1998;43(1):21–7.PubMedGoogle Scholar
  27. 27.
    Fowler DJ, Lindsay I, Seckl MJ, Sebire NJ. Histomorphometric features of hydatidiform moles in early pregnancy: relationship to detectability by ultrasound examination. Ultrasound Obstet Gynecol. 2007;29(1):76–80.PubMedCrossRefGoogle Scholar
  28. 28.
    Benson CB, Genest DR, Bernstein MR, Soto-Wright V, Goldstein DP, Berkowitz RS. Sonographic appearance of first trimester complete hydatidiform moles. Ultrasound Obstet Gynecol. 2000;16(2):188–91.PubMedCrossRefGoogle Scholar
  29. 29.
    Qiao S, Nagasaka T, Nakashima N. Numerous vessels detected by CD34 in the villous stroma of complete hydatidiform moles. Int J Gynecol Pathol. 1997;16(3):233–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Yoshida K, Nagasaka T, Nakashima N, Nishida Y, Saito M, Tomomitsu O. Elucidation of vascular structure of molar villi in complete hydatidiform mole by CD-34 antibody. Int J Gynecol Pathol. 2000;19(3):212–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Fisher RA, Paradinas FJ, Soteriou BA, Foskett M, Newlands ES. Diploid hydatidiform moles with fetal red blood cells in molar villi. 2 – Genetics. J Pathol. 1997;181(2):189–95.PubMedCrossRefGoogle Scholar
  32. 32.
    Paradinas FJ, Fisher RA, Browne P, Newlands ES. Diploid hydatidiform moles with fetal red blood cells in molar villi. 1 – Pathology, incidence, and prognosis. J Pathol. 1997;181(2):183–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Zaragoza MV, Keep D, Genest DR, Hassold T, Redline RW. Early complete hydatidiform moles contain inner cell mass derivatives. Am J Med Genet. 1997;70(3):273–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Baergen RN, Kelly T, McGinniss MJ, Jones OW, Benirschke K. Complete hydatidiform mole with a coexistent embryo. Hum Pathol. 1996;27(7):731–4.PubMedCrossRefGoogle Scholar
  35. 35.
    Lage JM, Bagg A. Hydatidiform moles: DNA flow cytometry, image analysis and selected topics in molecular biology. Histopathology. 1996;28(4):379–82.PubMedCrossRefGoogle Scholar
  36. 36.
    Gschwendtner A, Neher A, Kreczy A, Muller-Holzner E, Volgger B, Mairinger T. DNA ploidy determination of early molar pregnancies by image analysis: comparison to histologic classification. Arch Pathol Lab Med. 1998;122(11):1000–4.PubMedGoogle Scholar
  37. 37.
    Esteban JM, Sheibani K, Owens M, Joyce J, Bailey A, Battifora H. Effects of various fixatives and fixation conditions on DNA ploidy analysis. A need for strict internal DNA standards. Am J Clin Pathol. 1991;95(4):460–6.PubMedGoogle Scholar
  38. 38.
    Chilosi M, Piazzola E, Lestani M, Benedetti A, Guasparri I, Granchelli G, et al. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest. 1998;78(3):269–76.PubMedGoogle Scholar
  39. 39.
    McConnell TG, Murphy KM, Hafez M, Vang R, Ronnett BM. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach. Am J Surg Pathol. 2009;33(6):805–17.PubMedCrossRefGoogle Scholar
  40. 40.
    Kajii T, Ferrier A, Niikawa N, Takahara H, Ohama K, Avirachan S. Anatomic and chromosomal anomalies in 639 spontaneous abortuses. Hum Genet. 1980;55(1):87–98.PubMedCrossRefGoogle Scholar
  41. 41.
    Wake N, Seki T, Fujita H, Okubo H, Sakai K, Okuyama K, et al. Malignant potential of homozygous and heterozygous complete moles. Cancer Res. 1984;44(3):1226–30.PubMedGoogle Scholar
  42. 42.
    Bagshawe KD, Dent J, Webb J. Hydatidiform mole in England and Wales 1973–83. Lancet. 1986;2(8508):673–7.PubMedCrossRefGoogle Scholar
  43. 43.
    Garrett LA, Garner EI, Feltmate CM, Goldstein DP, Berkowitz RS. Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia. J Reprod Med. 2008;53(7):481–6.PubMedGoogle Scholar
  44. 44.
    Van den Veyver IB, Al-Hussaini TK. Biparental hydatidiform moles: a maternal effect mutation affecting imprinting in the offspring. Hum Reprod Update. 2006;12(3):233–42.PubMedCrossRefGoogle Scholar
  45. 45.
    van der Smagt JJ, Scheenjes E, Kremer JA, Hennekam FA, Fisher RA. Heterogeneity in the origin of recurrent complete hydatidiform moles: not all women with multiple molar pregnancies have biparental moles. BJOG. 2006;113(6):725–8.PubMedCrossRefGoogle Scholar
  46. 46.
    Kohorn EI. The new FIGO 2000 staging and risk ­factor scoring system for gestational trophoblastic disease: description and critical assessment. Int J Gynecol Cancer. 2001;11(1):73–7.PubMedCrossRefGoogle Scholar
  47. 47.
    Curry SL, Hammond CB, Tyrey L, Creasman WT, Parker RT. Hydatidiform mole: diagnosis, management, and long-term followup of 347 patients. Obstet Gynecol. 1975;45(1):1–8.PubMedGoogle Scholar
  48. 48.
    Kohorn EI. Hydatidiform mole and gestational trophoblastic disease in Southern Connecticut. Obstet Gynecol. 1982;59(1):78–84.PubMedGoogle Scholar
  49. 49.
    Lurain JR, Brewer JI, Torok EE, Halpern B. Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol. 1983;145(5):591–5.PubMedGoogle Scholar
  50. 50.
    Morrow CP, Kletzky OA, Disaia PJ, Townsend DE, Mishell DR, Nakamura RM. Clinical and laboratory correlates of molar pregnancy and trophoblastic disease. Am J Obstet Gynecol. 1977;128(4):424–30.PubMedGoogle Scholar
  51. 51.
    Genest DR, Laborde O, Berkowitz RS, Goldstein DP, Bernstein MR, Lage J. A clinicopathologic study of 153 cases of complete hydatidiform mole (1980–1990): histologic grade lacks prognostic significance. Obstet Gynecol. 1991;78(3 Pt 1):402–9.PubMedGoogle Scholar
  52. 52.
    Rice LW, Genest DR, Berkowitz RS, Goldstein DP, Bernstein MR, Redline RW. Pathologic features of sharp curettings in complete hydatidiform mole. Predictors of persistent gestational trophoblastic disease. J Reprod Med. 1991;36(1):17–20.PubMedGoogle Scholar
  53. 53.
    Siu MK, Wong ES, Chan HY, Ngan HY, Chan KY, Cheung AN. Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome. Am J Pathol. 2008;173(4):1165–72.PubMedCrossRefGoogle Scholar
  54. 54.
    Shih Ie M, Kuo KT. Power of the eternal youth: Nanog expression in the gestational choriocarcinoma. Am J Pathol. 2008;173(4):911–4.PubMedCrossRefGoogle Scholar
  55. 55.
    Paradinas FJ, Browne P, Fisher RA, Foskett M, Bagshawe KD, Newlands E. A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non-molar hydropic abortions. Histopathology. 1996;28(2):101–10.PubMedCrossRefGoogle Scholar
  56. 56.
    Wake N, Fujino T, Hoshi S, Shinkai N, Sakai K, Kato H, et al. The propensity to malignancy of dispermic heterozygous moles. Placenta. 1987;8(3):319–26.PubMedCrossRefGoogle Scholar
  57. 57.
    Cheung AN, Sit AS, Chung LP, Ngan HY, O’Hanlan K, Wong LC, et al. Detection of heterozygous XY complete hydatidiform mole by chromosome in situ hybridization. Gynecol Oncol. 1994;55(3 Pt 1):386–92.PubMedCrossRefGoogle Scholar
  58. 58.
    Lawler SD, Fisher RA. Genetic studies in hydatidiform mole with clinical correlations. Placenta. 1987;8(1):77–88.PubMedCrossRefGoogle Scholar
  59. 59.
    Niemann I, Sunde L, Petersen LK. Evaluation of the risk of persistent trophoblastic disease after twin pregnancy with diploid hydatidiform mole and coexisting normal fetus. Am J Obstet Gynecol. 2007;197(1):45e1–5.CrossRefGoogle Scholar
  60. 60.
    Niemann I, Hansen ES, Sunde L. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy. Gynecol Oncol. 2007;104(2):411–5.PubMedCrossRefGoogle Scholar
  61. 61.
    Matsui H, Sekiya S, Hando T, Wake N, Tomoda Y. Hydatidiform mole coexistent with a twin live fetus: a national collaborative study in Japan. Hum Reprod. 2000;15(3):608–11.PubMedCrossRefGoogle Scholar
  62. 62.
    Fishman DA, Padilla LA, Keh P, Cohen L, Frederiksen M, Lurain JR. Management of twin pregnancies consisting of a complete hydatidiform mole and normal fetus. Obstet Gynecol. 1998;91(4):546–50.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of PathologyYale University School of MedicineNew HavenUSA

Personalised recommendations